[go: up one dir, main page]

DOP2007000053A - Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo - Google Patents

Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo

Info

Publication number
DOP2007000053A
DOP2007000053A DO2007000053A DO2007000053A DOP2007000053A DO P2007000053 A DOP2007000053 A DO P2007000053A DO 2007000053 A DO2007000053 A DO 2007000053A DO 2007000053 A DO2007000053 A DO 2007000053A DO P2007000053 A DOP2007000053 A DO P2007000053A
Authority
DO
Dominican Republic
Prior art keywords
methods
compounds
tetrahydropiridotienopirimidina
preparation
treatment
Prior art date
Application number
DO2007000053A
Other languages
English (en)
Inventor
Zheng Liu
Jason Newcom
Chengzhi Zhang
Kanwar Sidhu
Mario Lobell
Gaetan Ladouce
Qian Zhao
Kristen Allegue
Chetan P Darne
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of DOP2007000053A publication Critical patent/DOP2007000053A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se relaciona con novedosos compuestos y con procesos para su preparacion, con rnetodos para el tratamiento de enfermedades, en especial el cancer, que comprenden la administracion de dichos compuestos, y con metocos para la preparacion de composiciones farmaceuticas para el tratamiento 0 prevencion de trastornos, especialmente el cancer.
DO2007000053A 2006-03-20 2007-03-20 Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo DOP2007000053A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78414606P 2006-03-20 2006-03-20

Publications (1)

Publication Number Publication Date
DOP2007000053A true DOP2007000053A (es) 2007-09-30

Family

ID=38523058

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2007000053A DOP2007000053A (es) 2006-03-20 2007-03-20 Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo

Country Status (29)

Country Link
US (1) US8501755B2 (es)
EP (1) EP2001890B1 (es)
JP (1) JP5282026B2 (es)
KR (1) KR20080110834A (es)
CN (1) CN101448840B (es)
AR (1) AR059901A1 (es)
AT (1) ATE495179T1 (es)
AU (1) AU2007227317A1 (es)
BR (1) BRPI0711045A2 (es)
CA (1) CA2647036C (es)
CR (1) CR10304A (es)
DE (1) DE602007011906D1 (es)
DO (1) DOP2007000053A (es)
EC (1) ECSP088749A (es)
ES (1) ES2357654T3 (es)
GT (1) GT200800187A (es)
IL (1) IL194028A0 (es)
MA (1) MA30351B1 (es)
MX (1) MX2008012006A (es)
NZ (1) NZ571326A (es)
PA (1) PA8719401A1 (es)
PE (1) PE20080144A1 (es)
RU (1) RU2008141239A (es)
SV (1) SV2008003032A (es)
TN (1) TNSN08370A1 (es)
TW (1) TW200804397A (es)
UY (1) UY30220A1 (es)
WO (1) WO2007109279A2 (es)
ZA (1) ZA200808017B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
EP2212332B1 (en) * 2007-09-14 2012-10-24 Bayer Intellectual Property GmbH Substituted tricyclic compounds and methods of use thereof
CN102264745B (zh) * 2008-11-10 2015-07-22 财团法人卫生研究院 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物
CA2861462A1 (en) * 2012-01-25 2013-08-01 Proteostasis Therapeutics, Inc. Proteasome activity modulating tricyclic compounds
US20170107229A1 (en) * 2014-05-26 2017-04-20 Bayer Pharma Aktiengesellschaft Substituted tetrahydropyridothienopyrimidines
EP3111960B1 (en) * 2015-07-03 2019-12-11 Kyoto University Nuclear medicine diagnostic imaging agent
MX385384B (es) 2016-06-22 2025-03-18 Univ Vanderbilt Moduladores alostericos positivos del receptor muscarinico de acetilcolina m4
JP7099725B2 (ja) 2016-11-07 2022-07-12 ヴァンダービルト ユニヴァーシティ ムスカリン性アセチルコリンレセプターｍ４のポジティブアロステリック調節因子
US11008335B2 (en) 2016-11-07 2021-05-18 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
CN116041365A (zh) 2016-11-07 2023-05-02 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
CN111406058A (zh) 2017-12-05 2020-07-10 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
TW201930311A (zh) 2017-12-05 2019-08-01 泛德比爾特大學 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑
WO2020191151A1 (en) * 2019-03-19 2020-09-24 Oncovalent Therapeutics Inc. Sumo inhibitor compounds and uses thereof
US20240391931A1 (en) * 2021-08-05 2024-11-28 Bristol-Myers Squibb Company Tricyclic fused pyrimidine compounds for use as her2 inhibitors
CN114736154B (zh) * 2022-03-15 2023-07-21 安庆朗坤药业有限公司 N-（3-氯-4-（2-吡啶甲氧基）苯基）-2-氰基乙酰胺的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000059912A1 (fr) 1999-03-30 2000-10-12 Nippon Soda Co., Ltd. Composes de thienopyrimidine et leurs sels, et procede de preparation desdits composes et sels
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
US7238701B2 (en) * 2003-07-24 2007-07-03 Bayer Pharmaceuticals Corporation Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders

Also Published As

Publication number Publication date
CR10304A (es) 2009-01-27
GT200800187A (es) 2009-04-07
EP2001890B1 (en) 2011-01-12
US20100298297A1 (en) 2010-11-25
UY30220A1 (es) 2007-10-31
CA2647036C (en) 2015-06-23
TW200804397A (en) 2008-01-16
AR059901A1 (es) 2008-05-07
JP2009530387A (ja) 2009-08-27
PE20080144A1 (es) 2008-04-06
ES2357654T3 (es) 2011-04-28
EP2001890A2 (en) 2008-12-17
WO2007109279A3 (en) 2007-12-21
BRPI0711045A2 (pt) 2012-06-26
WO2007109279A2 (en) 2007-09-27
CA2647036A1 (en) 2007-09-27
TNSN08370A1 (en) 2009-12-29
PA8719401A1 (es) 2009-02-09
MX2008012006A (es) 2008-10-03
IL194028A0 (en) 2009-09-22
ZA200808017B (en) 2009-11-25
ATE495179T1 (de) 2011-01-15
NZ571326A (en) 2011-07-29
JP5282026B2 (ja) 2013-09-04
ECSP088749A (es) 2008-10-31
MA30351B1 (fr) 2009-04-01
DE602007011906D1 (de) 2011-02-24
RU2008141239A (ru) 2010-04-27
KR20080110834A (ko) 2008-12-19
US8501755B2 (en) 2013-08-06
CN101448840A (zh) 2009-06-03
SV2008003032A (es) 2009-11-26
CN101448840B (zh) 2011-12-14
AU2007227317A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
PA8770101A1 (es) Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso
GT200500137A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
GT200500060A (es) Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos
GT200800184A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
PA8780201A1 (es) Derivados de pirasol sustituidos con heteroaril utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
CL2007002641A1 (es) Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias.
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
CR9347A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
GT200800214A (es) Antagonistas de los piridil amida de los canales de calcios de tipo t
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
ECSP10010042A (es) Compuestos y composiciones como moduladores de la actividad de gpr119
BR112014026703A2 (pt) inibidores de dna-pk
CR10099A (es) Inmunoglobulinas dirigidas contra nogo
TW200637614A (en) Bendamustine pharmaceutical compositions
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
UY31322A1 (es) Amidas heterocíclicas y sus métodos de uso-975
CR10305A (es) "derivados sustituidos de cromanol y su uso.
MX2010003269A (es) Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa.
CL2008000021A1 (es) Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer.
UA94036C2 (ru) Фармацевтическая композиция бендамустина, предназначенная для лиофилизации
DOP2005000025A (es) Compuestos de heteroaril- y fenilsulfamoilo sustituidos